Doximity: Business Model, SWOT Analysis, and Competitors 2026

Doximity, Inc. stands as a leading company in Healthcare. Generating $637.78 million in annual revenue (growing 9.8% year-over-year) and carrying a market capitalization of $4.80 billion, the company has cemented its position as a foundational player in the global Health Information Services landscape. Under the leadership of its leadership team, Doximity, Inc. continues to execute on a multi-year strategic vision that balances growth investment with shareholder returns.

This in-depth analysis examines Doximity, Inc.'s business model, financial performance, competitive positioning, and SWOT analysis as of 2026. Whether you're evaluating Doximity, Inc. as an investment, benchmarking it against peers, or researching its strategy, this guide covers the key factors that define Doximity, Inc.'s position in the Health Information Services market today.

What You Will Learn

1. How Doximity, Inc. generates revenue across its key business segments and the unit economics behind each
2. A data-backed SWOT analysis covering Doximity, Inc.'s competitive strengths, operational weaknesses, market opportunities, and external threats
3. Who Doximity, Inc.'s main competitors are and how the company compares on key financial metrics
4. Doximity, Inc.'s key financial metrics: revenue, profit margins, market cap, free cash flow, and valuation multiples
5. Doximity, Inc.'s strategic direction and what to watch in 2026-2027

Key Takeaways

• Revenue: $637.78 million annual revenue (TTM), +9.8% YoY
• Market Cap: $4.80 billion — one of the largest companies in the Healthcare sector
• Profitability: Gross margin 89.7%, operating margin 38.9%, net margin 37.5%
• Free Cash Flow: $213.63 million
• Return on Equity: 23.8% — strong
• Employees: 830 worldwide

Who Owns Doximity, Inc.?

Doximity, Inc. is publicly traded on the NYSE under the ticker symbol DOCS. As a public company, it is owned by millions of shareholders ranging from retail investors to major institutional holders.

The largest shareholders of Doximity, Inc. are typically major institutional investors including The Vanguard Group, BlackRock, and State Street Corporation — which collectively often hold 15-25% of publicly traded US companies. Insider ownership and the concentration of voting rights vary; investors should review the latest proxy statement filed with the SEC for precise ownership data.

Doximity, Inc. has approximately 134 million shares outstanding, with float shares of 131 million — the freely tradeable portion. The stock trades at $25.50 per share as of early 2026.

Doximity, Inc.'s Mission Statement

Doximity, Inc.'s strategic mission is aligned with its core business activities in the Health Information Services sector. The company's stated values and mission inform its capital allocation decisions, talent strategy, and long-term product roadmap. Mission statements for public companies are disclosed in annual reports and investor presentations — Doximity, Inc.'s most recent proxy statement and annual report are the authoritative sources for its current mission and values.

A company's mission statement matters because it signals strategic intent to employees, investors, and customers. For Doximity, Inc., the mission encompasses not just what the company does, but why it exists and how it creates value for stakeholders. Companies that maintain alignment between their stated mission and actual capital allocation decisions tend to build stronger brand trust and employee engagement over time.

In practice, Doximity, Inc.'s strategic priorities as communicated to investors in 2025-2026 center on revenue growth and market share expansion, profitability improvement, and sustainable returns of capital to shareholders. These operational priorities translate directly into the business model and investment thesis discussed in the following sections.

How Does Doximity, Inc. Make Money?

Doximity, Inc. operates as a digital platform for medical professionals in the United States. Its platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Doximity, Inc.'s business model is built around delivering value to its customers in the Health Information Services segment of the Healthcare sector. The company generates revenue through its core product and service offerings, leveraging its market position, operational capabilities, and customer relationships to sustain competitive advantage. Like most companies in Health Information Services, Doximity, Inc.'s financial performance is influenced by industry-wide pricing dynamics, input costs, and the balance between volume growth and margin management.

Management's strategic priorities — as disclosed in investor communications — focus on sustainable revenue growth, disciplined capital allocation, and building long-term shareholder value. Investors should review Doximity, Inc.'s latest annual report (10-K or equivalent) and quarterly earnings releases for the most current financial disclosures and strategic updates.

Doximity, Inc. Business Model Canvas

The Business Model Canvas framework provides a structured view of how Doximity, Inc. creates, delivers, and captures value.

Key Partners: Doximity, Inc.'s key partners include suppliers, distributors, technology providers, and strategic alliances that enable its core operations. In the Health Information Services sector, these relationships provide supply chain resilience, expanded distribution, and access to complementary capabilities.

Key Activities: Doximity, Inc.'s most important activities center on product development and innovation, sales and marketing, supply chain management, customer service, and regulatory compliance. The company's ability to execute these activities at scale is a core competency.

Key Resources: Doximity, Inc.'s critical resources include its brand equity, intellectual property portfolio, customer relationships, human capital (830 employees), proprietary technology, and financial resources ($735.13M in cash).

Value Propositions: Doximity, Inc. delivers value to customers through product quality, brand trust, convenience, innovation, and price competitiveness. The specific value proposition varies by customer segment but consistently addresses core needs in the Health Information Services market.

Customer Relationships: Doximity, Inc. maintains customer relationships through multiple channels including direct sales teams, digital platforms, customer service centers, and loyalty/membership programs. Customer retention is a key operational priority.

Channels: Doximity, Inc. reaches customers through its own direct channels (stores, website, apps), third-party retailers and distributors, and partner networks. The mix of direct vs. indirect channels affects margin structure and customer data ownership.

Customer Segments: Doximity, Inc. serves multiple distinct customer segments, which may include consumers, small and medium businesses, enterprise clients, and government entities — depending on its product portfolio and market positioning.

Cost Structure: Doximity, Inc.'s major costs include cost of goods sold (10.3% of revenue), research & development, sales & marketing, general & administrative expenses, and capital expenditures. Total operating costs represent 61.1% of revenue.

Revenue Streams: Doximity, Inc. generates revenue through its core product and service offerings.

Doximity, Inc. Competitors

Doximity, Inc. competes against Johnson & Johnson (JNJ), UnitedHealth Group (UNH), Pfizer (PFE), AbbVie (ABBV), Eli Lilly (LLY) and others in the Health Information Services segment of the Healthcare sector.

Company	Ticker	Market Cap	Revenue (TTM)	Gross Margin
Doximity, Inc.	DOCS	$4.80B	$637.78M	89.7%
Johnson & Johnson	JNJ	$577.48B	$94.19B	68.1%
UnitedHealth Group	UNH	$261.58B	$447.57B	18.5%
Pfizer	PFE	$151.30B	$62.58B	75.8%
AbbVie	ABBV	$410.83B	$61.16B	71.6%
Eli Lilly	LLY	$880.04B	$65.18B	83.0%

Doximity, Inc. SWOT Analysis

A SWOT analysis examines Doximity, Inc.'s internal strengths and weaknesses alongside external opportunities and threats.

Strengths

• Strong Margins: Doximity, Inc.'s gross margin of 89.7% is well above industry averages, reflecting pricing power, operational efficiency, or a high-value product mix. The operating margin of 38.9% demonstrates disciplined cost management even at scale.
• Capital Efficiency: A return on equity of 23.8% demonstrates that Doximity, Inc. generates strong returns from shareholder capital, a hallmark of companies with durable competitive advantages.

Weaknesses

• Competitive Scale Pressure: In the Health Information Services sector, larger competitors with greater economies of scale can exert pricing pressure and outspend Doximity, Inc. on marketing, R&D, and distribution — limiting the company's ability to defend market share in a price-sensitive environment.
• Market Concentration Risk: Revenue concentration in core markets or customer segments creates vulnerability to localized downturns, regulatory changes, or shifts in customer preferences. Diversification remains an ongoing strategic challenge.

Opportunities

• Total Addressable Market: Doximity, Inc. operates in the Health Information Services segment of the broader Healthcare sector, which represents a $12 trillion global healthcare market by 2030. Even modest share gains in this environment translate to meaningful revenue upside, particularly as the company expands its product portfolio and geographic reach.
• International Expansion: Emerging markets — particularly India (1.4B people, rapidly growing middle class), Southeast Asia (700M people), and Sub-Saharan Africa — represent significant untapped addressable markets for Doximity, Inc.'s products and services.
• Strategic Acquisitions: With $735.13M in cash and strong free cash flow generation, Doximity, Inc. is well-positioned to pursue strategic acquisitions that expand its capabilities, customer base, or geographic reach.

Threats

• Macroeconomic Sensitivity: Global economic slowdowns, inflation, or rising interest rates can reduce consumer and enterprise spending. Doximity, Inc.'s revenue is not fully insulated from macroeconomic cycles, and a recession scenario could meaningfully impact demand.
• Regulatory and Geopolitical Risk: Increasing government regulation — particularly data privacy laws (GDPR, CCPA), antitrust enforcement, and trade restrictions — poses compliance costs and potential restrictions on Doximity, Inc.'s business model across key markets.
• Talent Competition: Competition for skilled technology, engineering, and management talent remains intense. High employee turnover or inability to attract top talent could slow innovation and execution — particularly critical in an era of AI-driven competition.

Conclusion

Doximity, Inc. enters 2026 as a leading company in Healthcare, backed by $637.78 million in annual revenue and a 37.5% net profit margin. The company's 89.7% gross margins and $213.63 million in free cash flow provide the financial foundation to fund growth initiatives while returning capital to shareholders.

The primary opportunities ahead lie in expanding market share, operational efficiency improvements, and selective geographic expansion. The key risks to monitor include competitive pressure from established peers and new entrants, macroeconomic headwinds, and regulatory developments in Doximity, Inc.'s core markets.

For investors, Doximity, Inc.'s 21.4x trailing P/E and 15.7x forward P/E reflect the market's expectations for stable earnings. Analysts and investors should watch quarterly earnings releases, management commentary on comparable sales growth, margin trends, and capital allocation for signals of how the investment thesis is progressing.

Frequently Asked Questions

1. What does Doximity, Inc. do?

Doximity, Inc. operates as a digital platform for medical professionals in the United States. Its platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their care

2. How much revenue does Doximity, Inc. make?

Doximity, Inc. generated $637.78 million in annual revenue (TTM), with 9.8% year-over-year growth.

3. What is Doximity, Inc.'s market cap?

Doximity, Inc.'s market capitalization is approximately $4.80 billion as of early 2026.

4. Is Doximity, Inc. profitable?

Yes. Doximity, Inc. has a net profit margin of 37.5% and a return on equity of 23.8%.

5. Who are Doximity, Inc.'s competitors?

Doximity, Inc. competes in the Health Information Services sector against companies including Johnson & Johnson (JNJ), UnitedHealth Group (UNH), Pfizer (PFE).

6. Does Doximity, Inc. pay dividends?

Doximity, Inc. does not currently pay a dividend, choosing to reinvest earnings into growth initiatives.

7. What is Doximity, Inc.'s stock ticker?

Doximity, Inc. trades on the NYSE under the ticker symbol DOCS.

8. What is Doximity, Inc.'s P/E ratio?

Doximity, Inc.'s trailing P/E ratio is 21.4x and forward P/E is 15.7x, suggesting the market anticipates continued earnings growth.

9. How many employees does Doximity, Inc. have?

Doximity, Inc. employs approximately 830 people worldwide as of the most recent disclosure.

10. What is Doximity, Inc.'s competitive advantage?

Doximity, Inc.'s competitive advantages include its established brand, scale in Health Information Services, and track record of execution in the Healthcare sector.